GlassScriptPhysician profile
Megan C Reichmuth
NPI 1932544855
$4,290.79
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,581 · 2020: $354 · 2021: $59.04 · 2022: $262 · 2023: $34.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $2,870.14 | 2019 | |
| Grifols USA, LLC | $388.66 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $250.00 | 2019 | |
| Intercept Pharmaceuticals, INC. | $240.83 | 2019-2020 | |
| Insmed, INC. | $138.89 | 2019-2020 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $73.64 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.06 | 2019 | |
| Philips North America LLC | $61.03 | 2020-2023 | |
| Abbvie INC. | $22.23 | 2022 | |
| Veran Medical Technologies, INC. | $18.43 | 2019-2020 | |
| Genzyme Corporation | $16.64 | 2022 | |
| Ani Pharmaceuticals, INC. | $14.22 | 2023 | Purified Cortrophin Gel |
| Amgen INC. | $14.13 | 2022 | |
| Inogen, INC. | $11.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $2.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Reichmuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.